-
Understanding Pulmonary Rehab
Pulmonary rehab expert Debbie Koehl, MS, RRT-NPS, AE-C, FAARC, speaks to LUNGevity's Survivorship Navigator, Kristi Griffith, to explain what pulmonary rehabilitation is, explore... -
Pneumonitis: A Common Side Effect
In this video, nurse practitioner Lauren Welch, MSN, NP-C, AOCNP, from the Sarah Cannon Research Institute at Tennessee Oncology offers a quick review of pneumonitis - a common... -
Celebrate Lung Cancer Awareness Month
Every fall, the lung cancer community gathers to raise awareness for this disease and stand together – unified and strong. November is Lung Cancer Awareness Month – a time to come... -
Important Advice for Patients with Newly Diagnosed EGFR-Positive Lung Cancer
Lung cancer expert Dr. Zosia Piotrowska speaks with Dr. Amy Moore, LUNGevity’s VP of Global Engagement and Patient Partnerships, to discuss the key information everyone with newly... -
Get the Answers You Need
Whether you are newly diagnosed or a long-term survivor, LUNGevity offers lung cancer support and survivorship services to address your unique needs. LUNGevity's services are... -
Introduction to Radiation Therapy
Lung cancer survivor Jill Feldman joins radiation therapy experts Drs. Drew Moghanaki and Kristin Higgins to provide an overview of radiation therapy – including discussions of... -
Caregiver Starter Kit: 5 Resources
Navigating a lung cancer diagnosis can feel overwhelming not only to the patient but to their caregiver as well. It’s normal to feel lost or confused and not know where to start or... -
All About Biomarker Testing & KRAS+ Lung Cancer
Patient Rosemary Conway was joined by LUNGevity's Dr. Amy Moore and Hatim Husain, an oncologist at UCSD, to discuss biomarker testing and progress in KRAS-positive lung cancer. -
-
What to Expect When Diagnosed with ALK+ Lung Cancer
In this presentation, Upal Basu Roy, PhD, MPH, LUNGevity's executive director of research, speaks with Justin Gainor, MD, about what people with newly diagnosed ALK-positive lung... -
World Lung Cancer Day and the Changing Landscape of Lung Cancer
For decades, lung cancer was synonymous with low survival rates, limited treatment options, and poor quality of life for those living with the disease. Each year, more than 236,000... -
Lung Cancer Treatment Landscape: New Options and Ongoing Challenges
Drs. Upal Basu Roy, Amy Moore, and Dhru Deb discuss their recent publication in which they presented an analysis of the lung cancer drug pipeline. They talk about what it means for...
Patient Gateway